Investigation of a treatment to reduce itching in dogs with atopic dermatitis
Study title: Investigation of a treatment to reduce itching in dogs with atopic dermatitis
Current Status: Active and enrolling
Principal Investigator: Sheila Torres, DVM, MS, PhD, DACVD, [email protected], 612-625-3715
Contact: Andrea Chehadeh, Senior Research Study Technician, [email protected], 612-625-3157
The purpose of this clinical study is to investigate a treatment to reduce itching in dogs with atopic dermatitis (AD). This is a double-blinded study, meaning neither the investigator (Dr. Torres) nor the owner will know which treatment the dog has received.
- Dogs with a history of chronic, non-seasonal AD for at least one year
- Dogs with other causes of itch ruled out or in some cases, controlled: such as food allergy, flea allergy, bacterial or fungal dermatitis, ear infection, parasites, etc.
- Owners willing to keep their dog on flea/tick prevention during the study
- Dogs with active bacterial or fungal infection should be treated before enrolling in the study
- Certain medications will require withdrawal prior to enrollment
- Other criteria apply, please contact us for details.
Each dog will complete 10 visits to the Veterinary Medical Center (VMC) in a 4-month period for exams, assessments, and sample collection (blood and urine). Owners will have forms to fill out, online or on paper, at home and in the clinic.
Cost of the study:
Once enrolled, the study will pay for the costs of the visits listed above as long as they are performed at the VMC. The screening visit is at the owner’s expense unless enrolled; costs can range between $200 - $500. Upon completion, owners will be eligible for a debit card for participating in the study.
To learn more or to enroll, please contact Andrea Chehadeh or Dr. Torres (above).